PRCT Projected Dividend Yield
PROCEPT BioRobotics Corp ( NASDAQ : PRCT )PROCEPT BioRobotics is a surgical robotics company dedicated to advancing urology care. Co. develop, manufacture, and sell the AquaBeam Robotic System, an image-guided system for minimally invasive urologic surgery, primarily for treating benign prostatic hyperplasia (BPH). The AquaBeam system uses a single-use handpiece to deliver Aquablation therapy, which combines real-time imaging, personalized treatment planning, automated robotics, and heat-free waterjet ablation for precise prostate tissue removal. This therapy aims to provide effective, safe, and durable outcomes for men with lower urinary tract symptoms due to BPH, regardless of prostate size, shape, or surgeon experience. 21 YEAR PERFORMANCE RESULTS |
PRCT Dividend History Detail PRCT Dividend News PRCT Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |